| Item Type | Name |
|
Concept
|
Acetylation
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Angioplasty, Balloon
|
|
Concept
|
Antigens, Viral
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Antigens, Differentiation
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Animals
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Epitopes
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Histocompatibility Antigens Class II
|
|
Concept
|
Base Sequence
|
|
Concept
|
Autoantigens
|
|
Concept
|
Binding Sites
|
|
Concept
|
Encephalomyelitis, Autoimmune, Experimental
|
|
Concept
|
Capsid
|
|
Concept
|
Cattle
|
|
Concept
|
Cell Transformation, Neoplastic
|
|
Concept
|
Codon
|
|
Concept
|
Glutathione Transferase
|
|
Concept
|
Histamine
|
|
Concept
|
Dactinomycin
|
|
Concept
|
Cysteine Endopeptidases
|
|
Concept
|
Dexamethasone
|
|
Concept
|
Dichlororibofuranosylbenzimidazole
|
|
Concept
|
Interleukins
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Dose-Response Relationship, Radiation
|
|
Concept
|
Cytotoxins
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Ethylmaleimide
|
|
Concept
|
Interferons
|
|
Concept
|
Introns
|
|
Concept
|
Multienzyme Complexes
|
|
Concept
|
Genes, Viral
|
|
Concept
|
Glioma
|
|
Concept
|
Glioblastoma
|
|
Concept
|
Genetic Complementation Test
|
|
Concept
|
Dyneins
|
|
Concept
|
DNA, Viral
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Laryngeal Neoplasms
|
|
Concept
|
Herpesvirus 4, Human
|
|
Concept
|
Hydroxamic Acids
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Hemagglutinins, Viral
|
|
Concept
|
Hyperplasia
|
|
Concept
|
Mice, Inbred CBA
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Organ Culture Techniques
|
|
Concept
|
Muscle, Smooth, Vascular
|
|
Concept
|
Oxidoreductases, N-Demethylating
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Cricetinae
|
|
Concept
|
Hot Temperature
|
|
Concept
|
Nucleic Acid Conformation
|
|
Concept
|
Luciferases
|
|
Concept
|
Membrane Fusion
|
|
Concept
|
Microscopy, Electron
|
|
Concept
|
Histone Deacetylases
|
|
Concept
|
Receptors, Fc
|
|
Concept
|
Recurrence
|
|
Concept
|
Rabbits
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
Virology
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
ROC Curve
|
|
Concept
|
Genes, ras
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Swine
|
|
Concept
|
Humans
|
|
Concept
|
Leupeptins
|
|
Concept
|
Tosylphenylalanyl Chloromethyl Ketone
|
|
Concept
|
Interferon Type I
|
|
Concept
|
Truth Disclosure
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Viral Fusion Proteins
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
Liver Neoplasms, Experimental
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Caspases
|
|
Concept
|
Models, Animal
|
|
Concept
|
S Phase
|
|
Concept
|
Central Nervous System Neoplasms
|
|
Concept
|
Electrophoretic Mobility Shift Assay
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Mutagenesis
|
|
Concept
|
Mitochondria
|
|
Concept
|
Interleukin-4
|
|
Concept
|
Cysteine Proteinase Inhibitors
|
|
Concept
|
Interleukin-8
|
|
Concept
|
Interleukin-10
|
|
Concept
|
Mutagenesis, Site-Directed
|
|
Concept
|
Microscopy, Immunoelectron
|
|
Concept
|
Antigens, Nuclear
|
|
Concept
|
Capsid Proteins
|
|
Concept
|
Protein Structure, Tertiary
|
|
Concept
|
Genes, Immediate-Early
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Ubiquitin Thiolesterase
|
|
Concept
|
Interferon-alpha
|
|
Concept
|
Antigen Presentation
|
|
Concept
|
Gene Deletion
|
|
Concept
|
Sequence Deletion
|
|
Concept
|
Receptors, Tumor Necrosis Factor
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Receptors, Interferon
|
|
Concept
|
DNA, Complementary
|
|
Concept
|
History, 18th Century
|
|
Concept
|
Interleukin-12
|
|
Concept
|
Interferon-Stimulated Gene Factor 3
|
|
Concept
|
Interferon-Stimulated Gene Factor 3, gamma Subunit
|
|
Concept
|
Helix-Loop-Helix Motifs
|
|
Concept
|
Spodoptera
|
|
Concept
|
Caspase 3
|
|
Concept
|
Receptors, Tumor Necrosis Factor, Member 14
|
|
Concept
|
Encephalitis, Herpes Simplex
|
|
Concept
|
MAP Kinase Kinase Kinases
|
|
Concept
|
Mutation, Missense
|
|
Concept
|
Fluorescent Antibody Technique, Indirect
|
|
Concept
|
AT Rich Sequence
|
|
Concept
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
|
|
Concept
|
Oncogene Proteins, Viral
|
|
Concept
|
Ubiquitin-Conjugating Enzymes
|
|
Concept
|
Iron-Binding Proteins
|
|
Concept
|
Receptors, Tumor Necrosis Factor, Type I
|
|
Concept
|
Green Fluorescent Proteins
|
|
Concept
|
History, 21st Century
|
|
Concept
|
Papillomavirus E7 Proteins
|
|
Concept
|
Octamer Transcription Factor-1
|
|
Concept
|
Cyclin-Dependent Kinase 4
|
|
Concept
|
Proteasome Endopeptidase Complex
|
|
Concept
|
COS Cells
|
|
Concept
|
Microscopy, Confocal
|
|
Concept
|
Amino Acid Substitution
|
|
Concept
|
5' Untranslated Regions
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
3' Untranslated Regions
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
Nerve Growth Factor
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
SUMO-1 Protein
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Mice
|
|
Concept
|
Inositol 1,4,5-Trisphosphate Receptors
|
|
Concept
|
Tandem Mass Spectrometry
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Host-Pathogen Interactions
|
|
Concept
|
Histone Deacetylase 2
|
|
Concept
|
Multiprotein Complexes
|
|
Concept
|
Retinoblastoma-Binding Protein 1
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Chemokine CXCL10
|
|
Concept
|
Immunoblotting
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Protein Interaction Domains and Motifs
|
|
Concept
|
STAT2 Transcription Factor
|
|
Concept
|
Serine Proteinase Inhibitors
|
|
Concept
|
CDC2 Protein Kinase
|
|
Concept
|
Histone Deacetylase 1
|
|
Concept
|
RNA, Antisense
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Receptor, IGF Type 2
|
|
Concept
|
Receptors, Interleukin
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
G2 Phase
|
|
Concept
|
Baculoviridae
|
|
Concept
|
Genes, fos
|
|
Concept
|
Interferon-beta
|
|
Concept
|
Proliferating Cell Nuclear Antigen
|
|
Concept
|
Cyclin-Dependent Kinases
|
|
Concept
|
Interleukin-13 Receptor alpha1 Subunit
|
|
Concept
|
Butyric Acid
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Ubiquitin
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Interleukin-13
|
|
Concept
|
Histone Demethylases
|
|
Concept
|
Histone Deacetylase Inhibitors
|
|
Concept
|
Phosphatidylinositol 3-Kinases
|
|
Concept
|
MAP Kinase Signaling System
|
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
|
Concept
|
History, 20th Century
|
|
Concept
|
E2F1 Transcription Factor
|
|
Concept
|
STAT1 Transcription Factor
|
|
Concept
|
p300-CBP Transcription Factors
|
|
Concept
|
CLOCK Proteins
|
|
Concept
|
Immune Evasion
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
CDC2-CDC28 Kinases
|
|
Concept
|
History, 19th Century
|
|
Concept
|
Cyclin-Dependent Kinase 6
|
|
Concept
|
Human papillomavirus 16
|
|
Concept
|
Receptors, Interleukin-13
|
|
Concept
|
Protein Phosphatase 2
|
|
Concept
|
Receptors, Urokinase Plasminogen Activator
|
|
Concept
|
Exosomes
|
|
Concept
|
Cyclin T
|
|
Concept
|
Antibodies
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Calcium
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Data Interpretation, Statistical
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
DNA, Single-Stranded
|
|
Concept
|
Epidermal Growth Factor
|
|
Concept
|
Graft Occlusion, Vascular
|
|
Concept
|
Health Personnel
|
|
Concept
|
Microscopy, Fluorescence
|
|
Concept
|
Models, Biological
|
|
Concept
|
Nuclear Envelope
|
|
Concept
|
Receptors, Virus
|
|
Concept
|
Romania
|
|
Concept
|
Vaccines, Synthetic
|
|
Concept
|
Cytokines
|
|
Concept
|
Mutagenesis, Insertional
|
|
Concept
|
DNA Primers
|
|
Concept
|
Coculture Techniques
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Cyclin-Dependent Kinase 9
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
|
Concept
|
Nuclear Export Signals
|
|
Concept
|
Octamer Transcription Factors
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Cyclin-Dependent Kinase 2
|
|
Concept
|
RING Finger Domains
|
|
Concept
|
Laboratory Personnel
|
|
Academic Article
|
Redefining virology.
|
|
Academic Article
|
Replication-competent herpes simplex viral vectors for cancer therapy.
|
|
Academic Article
|
An early regulatory function required in a cell type-dependent manner is expressed by the genomic but not the cDNA copy of the herpes simplex virus 1 gene encoding infected cell protein 0.
|
|
Academic Article
|
E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.
|
|
Academic Article
|
Wild-type herpes simplex virus 1 blocks programmed cell death and release of cytochrome c but not the translocation of mitochondrial apoptosis-inducing factor to the nuclei of human embryonic lung fibroblasts.
|
|
Academic Article
|
U(S)3 protein kinase of herpes simplex virus 1 blocks caspase 3 activation induced by the products of U(S)1.5 and U(L)13 genes and modulates expression of transduced U(S)1.5 open reading frame in a cell type-specific manner.
|
|
Academic Article
|
Herpes simplex viruses: is a vaccine tenable?
|
|
Academic Article
|
The herpes simplex virus 1 UL41 gene-dependent destabilization of cellular RNAs is selective and may be sequence-specific.
|
|
Academic Article
|
The U(S)3 protein kinase blocks apoptosis induced by the d120 mutant of herpes simplex virus 1 at a premitochondrial stage.
|
|
Academic Article
|
The UL41 protein of herpes simplex virus mediates selective stabilization or degradation of cellular mRNAs.
|
|
Academic Article
|
The stress-inducible immediate-early responsive gene IEX-1 is activated in cells infected with herpes simplex virus 1, but several viral mechanisms, including 3' degradation of its RNA, preclude expression of the gene.
|
|
Academic Article
|
Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
|
|
Academic Article
|
The U(L)41 protein of herpes simplex virus 1 degrades RNA by endonucleolytic cleavage in absence of other cellular or viral proteins.
|
|
Academic Article
|
State and role of SRC family kinases in replication of herpes simplex virus 1.
|
|
Academic Article
|
Bcl-2 blocks accretion or depletion of stored calcium but has no effect on the redistribution of IP3 receptor I mediated by glycoprotein E of herpes simplex virus 1.
|
|
Academic Article
|
Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.
|
|
Academic Article
|
Checkpoints in productive and latent infections with herpes simplex virus 1: conceptualization of the issues.
|
|
Academic Article
|
Small dense nuclear bodies are the site of localization of herpes simplex virus 1 U(L)3 and U(L)4 proteins and of ICP22 only when the latter protein is present.
|
|
Academic Article
|
Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications.
|
|
Academic Article
|
Post-transcriptional processing of cellular RNAs in herpes simplex virus-infected cells.
|
|
Academic Article
|
Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptor.
|
|
Academic Article
|
Nuclear retention of ICP0 in cells exposed to HDAC inhibitor or transfected with DNA before infection with herpes simplex virus 1.
|
|
Academic Article
|
HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed.
|
|
Academic Article
|
Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression.
|
|
Academic Article
|
RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.
|
|
Academic Article
|
Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retention.
|
|
Academic Article
|
Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation.
|
|
Academic Article
|
Tristetraprolin Recruits the Herpes Simplex Virion Host Shutoff RNase to AU-Rich Elements in Stress Response mRNAs To Enable Their Cleavage.
|
|
Academic Article
|
The stability of herpes simplex virus 1 ICP0 early after infection is defined by the RING finger and the UL13 protein kinase.
|
|
Academic Article
|
The 3 facets of regulation of herpes simplex virus gene expression: A critical inquiry.
|
|
Concept
|
Promyelocytic Leukemia Protein
|
|
Concept
|
DEAD Box Protein 58
|
|
Concept
|
NF-KappaB Inhibitor alpha
|
|
Concept
|
Betacoronavirus
|
|
Concept
|
Nectins
|
|
Concept
|
Ubiquitin-Specific Peptidase 7
|
|
Concept
|
Caspase Inhibitors
|
|
Concept
|
AU Rich Elements
|
|
Concept
|
Exosome Multienzyme Ribonuclease Complex
|
|
Concept
|
ErbB Receptors
|
|
Grant
|
Selective Degradation of mRNA by Herpes Simplex Virus 1
|
|
Grant
|
Dissection of the Functions of Herpes Simplex Virus ICPO
|
|
Grant
|
MECHANISMS OF VIRAL INFECTION IN RELATION TO CANCER
|